Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice

Genes, Brain and Behavior

Volumn 13, Issue 3, 2014, Pages 286-298

  Brielmaier, J ^a,e   Senerth, J M ^a   Silverman, J L ^a,f   Matteson, P G ^b   Millonig, J H ^b,c   Dicicco Bloom, E ^c,d   Crawley, J N ^a,f  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Center for Biotechnology and Medicine   (United States)

^c Department of Neuroscience and Cell Biology ^*  (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e GEORGE MASON UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Depression; Desipramine; Knockout mouse; Norepinephrine; Social behavior

Indexed keywords

DESIPRAMINE; ENGRAILED 2 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; DEPRESSION; FEAR; FEMALE; FORCED SWIM TEST; IMMOBILITY; KNOCKOUT MOUSE; LONG TERM CARE; MALE; MOUSE; NEUROMODULATION; NONHUMAN; NORADRENERGIC SYSTEM; PHENOTYPE; PRIORITY JOURNAL; SOCIAL DISABILITY; SOCIAL STATUS; TAIL SUSPENSION TEST; TASK PERFORMANCE;

MUS;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; COGNITION DISORDERS; DEPRESSION; DESIPRAMINE; FEAR; HOMEODOMAIN PROTEINS; LOCOMOTION; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; SOCIAL BEHAVIOR;

EID: 84896723746     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12115     Document Type: Article

References (45)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Vol. 27. American Psychiatric Association, Washington, DC.
2. Auerbach, B.D., Osterweil, E.K. & Bear, M.F. (2011) Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63-68.
3. Baader, S.L., Sanlioglu, S., Berrebi, A.S., Parker-Thornburg, J. & Oberdick, J. (1998) Ectopic overexpression of Engrailed-2 in cerebellar Purkinje cells causes restricted cell loss and retarded external germinal layer development at lobule junctions. J Neurosci 18, 1763-1773.
4. Balu, D.T., Hodes, G.E., Anderson, B.T. & Lucki, I. (2009) Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments. Neuropsychopharmacology 34, 1764-1773.
5. Bevins, R.A. & Besheer, J. (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc 1, 1306-1311.
6. Brielmaier, J., Matteson, P.G., Silverman, J.L., Senerth, J.M., Kelly, S., Genestine, M., Millonig, J.H., DiCicco-Bloom, E. & Crawley, J.N. (2012) Autism-relevant social abnormalities and cognitive deficits in Engrailed-2 knockout mice. PLoS One 7, e40914.
7. Bunney, W. & Davis, J. (1965) Norepinephrine in depressive reactions: a review. Arch Gen Psychiatry 13, 483-494.
8. Centers for Disease Control (2012) Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008. MMWR Surveill Summ 61 (SS03), 1-19.
9. Cheh, M.A., Millonig, J.H., Roselli, L.M., Ming, X., Jacobsen, E., Kamdar, S. & Wagner, G.C. (2006) En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Res 1116, 166-176.
10. Choi, J., Kamdar, S., Rahman, T., Matteson, P.G. & Millonig, J.H. (2011) ENGRAILED 2 (EN2) genetic and functional analysis. In Williams, T. (ed), Autism Spectrum Disorders - From Genes to Environment. InTech, Rijeka, pp. 3-22.
11. Choi, J., Ababon, M.R., Matteson, P.G. & Millonig, J.H. (2012) Cut-like homeobox 1 and nuclear factor I/B mediate ENGRAILED2 autism spectrum disorder-associated haplotype function. Hum Mol Genet 21, 1566-1580.
12. Courchesne, E. (1997) Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr Opin Neurobiol 7, 269-278.
13. Cryan, J.F. & Mombereau, C. (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9, 326-357.
14. Cryan, J.F., Mombereau, C. & Vassout, A. (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29 (4-5), 571-625.
15. Dell'Osso, B., Palazzo, M.C., Oldani, L. & Altamura, A.C. (2011) The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects. CNS Neurosci Ther 17, 723-732.
16. Dulawa, S.C., Holick, K.A., Gundersen, B. & Hen, R. (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29, 1321-1330.
17. Genestine, M., Lin, L., Yan, Y., Prem, S., Sonsalla, P.K., Millonig, J.H. & DiCicco-Bloom, E. (2011) Absence of Engrailed 2 (En2), the autism spectrum disorder (ASD) associated gene, alters locus coeruleus fiber elaboration and hippocampal neurogenesis and apoptosis. Society for Neuroscience 747.09.
18. Gordon, C.T., Rapoport, J.L., Hamburger, S.D., State, R.C. & Mannheim, G.B. (1992) Differential response of seven subjects with autistic disorder to clomipramine and desipramine. Am J Psychiatry 149, 363-366.
19. Gordon, C.T., State, R.C., Nelson, J.E., Hamburger, S.D. & Rapoport, J.L. (1993) A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 50, 441-447.
20. Hammond, R.S., Tull, L.E. & Stackman, R.W. (2004) On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 82, 26-34.
21. Holick, K.A., Lee, D.C., Hen, R. & Dulawa, S.C. (2008) Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 33, 406-417.
22. Joyner, A.L. (1996) Engrailed, Wnt and Pax genes regulate midbrain--hindbrain development. Trends Genet 12, 15-20.
23. Joyner, A.L., Skarnes, W.C. & Rossant, J. (1989) Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells. Nature 338, 153-156.
24. Katz, M.M., Koslow, S.H., Maas, J.W., Frazer, A., Bowden, C.L., Casper, R., Croughan, J., Kocsis, J. & Redmond, E Jr. (1987) The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 17, 297-309.
25. Kuemerle, B., Zanjani, H., Joyner, A. & Herrup, K. (1997) Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development. J Neurosci 17, 7881-7889.
26. Lin, L.L., Genestine, M., Yan, Y., Sonsalla, P.K., Matteson, P.G., Silverman, J.L., Crawley, J.N., Millonig, J.H. & DiCicco-Bloom, E. (2010) Deficiency of Engrailed 2 (En2) produces abnormal development of forebrain-projecting, monoamine neurotransmitter systems and depression-related behaviors. International Meeting for Autism Research.
27. Lord, C., Risi, S., Lambrecht, L., Cook, E.H., Leventhal, B.L., DiLavore, P.C., Pickles, A. & Rutter, M. (2000) The Autism Diagnostic Observation Schedule-Generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30, 205-223.
28. Lucki, I. (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8 (6-7), 523-532.
29. Lucki, I., Dalvi, A. & Mayorga, A. (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155, 315-322.
30. Lund, A., Tjolsen, A. & Hole, K. (1989) Desipramine in small doses induces antinociception in the increasing temperature hot-plate test, but not in the tail-flick test. Neuropharmacology 28, 1169-1173.
31. Malhotra, D., McCarthy, S., Michaelson, J.J. et al. (2011) High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 72, 951-963.
32. Moore, R.Y. & Bloom, F.E. (1979) Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci 2, 113-168.
33. Nemeroff, C.B. (2002) Recent advances in the neurobiology of depression. Psychopharmacol Bull 36 (Suppl. 2), 6-23.
34. Nierenberg, A.A. (2001) Do some antidepressants work faster than others? J Clin Psychiatry 62 (Suppl. 15), 22-25.
35. Phillips, R.G. & LeDoux, J.E. (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106, 274-285.
36. Ramocki, M.B. & Zoghbi, H.Y. (2008) Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 455, 912-918.
37. Ritvo, E.R., Freeman, B.J. & Scheibel, A.B. (1986) Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC autopsy research report. Am J Psychiatry 143, 862-866.
38. Rojas-Corrales, M.O., Casas, J., Moreno-Brea, M.R., Gibert-Rahola, J. & Micó, J.A. (2003) Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites. Eur Neuropsychopharmacol 13, 355-363.
39. Saxe, M.D., Battaglia, F., Wang, J.-W., Malleret, G., David, D.J., Monckton, J.E., Garcia, A.D., Sofroniew, M.V., Kandel, E.R., Santarelli, L., Hen, R. & Drew M.R. (2006) Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc Natl Acad Sci U S A 103, 17501-17506.
40. Sillitoe, R.V., Vogel, M.W. & Joyner, A.L. (2010) Engrailed homeobox genes regulate establishment of the cerebellar afferent circuit map. J Neurosci 30, 10015-10024.
41. Simon, H.H., Scholz, C. & O'Leary, D.D. (2005) Engrailed genes control developmental fate of serotonergic and noradrenergic neurons in mid- and hindbrain in a gene dose-dependent manner. Mol Cell Neurosci 28, 96-105.
42. Steru, L., Chermat, R., Thierry, B. & Simon, P. (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85, 367-370.
43. Winters, B.D. & Bussey, T.J. (2005) Transient inactivation of perirhinal cortex disrupts encoding, retrieval, and consolidation of object recognition memory. J Neurosci 25, 52-61.
44. Wong, E.H.F., Sonders, M.S., Amara, S.G., Tinholt, P.M., Piercey, M.F.P., Hoffmann, W.P., Hyslop, D.K., Franklin, S., Porsolt, R.D., Bonsignori, A., Carfagna, N. & McArthur, R.A. (2000) Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry 47, 818-829.
45. Yang, M., Silverman, J.L. & Crawley, J.N. (2011) Automated three-chambered social approach task for mice. Curr Protoc Neurosci 56, 8.26.